Latest News

NEW YORK, May 23, 2023 -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that they are now participating on the new...

NEW YORK, May 17, 2023 -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that its Chief Medical Officer is presenting at...

• There are no effective treatments for intracerebral hemorrhage (ICH), which has a 30% to 40% mortality rate
• Intranasal anti-CD3 mAb treatment showed a reduction...

NEW YORK, April 26, 2023 – Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced financial results for the twelve months ended December 31,...

NEW YORK, April 24, 2023 -- Tiziana Life Sciences Ltd.. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announces that it has received a notification from the Nasdaq...

• Application for $3M of non-dilutive funding for Phase 2a Alzheimer’s trial will be submitted in Q2 2023
• Tiziana guided by FDA Type “B” meeting...

• CD3 antibody has emerged as an established and attractive target for Type 1 diabetes after the $2.9 billion acquisition of Provention Bio by Sanofi
• Mechanism of Action of Tiziana’s...

• Long COVID remains a high unmet need causing a myriad of complications for patients and costing the U.S. healthcare system an estimated $2.6 trillion...

• Exhibition will run from March 31^st to May 21^st, 2023, at Prada Rong Zhai
• Scientific Conference will be held on April 20^th, 2023, at Prada Rong Zhai

NEW YORK, April...

• Dr. Saef Izzy’s data shows one-month behavioral outcomes improvement in model of intracerebral hemorrhage (hemorrhagic stroke)
• Modulation of neuroinflammation by inducing FoxP3+ Tregs appears...